跳至主要内容
临床试验/NCT05199701
NCT05199701进行中(未招募)不适用

Prospective Case Collection Study for New Mammography Technologies

Hologic, Inc.29 个研究点 分布在 1 个国家目标入组 7,500 人开始时间: 2021年12月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Hologic, Inc.
入组人数
7,500
试验地点
29
主要终点
Clinically acceptable image quality of the Investigational Device.

研究概览

简要总结

To evaluate the safety and efficacy of the proposed investigational device and assess its clinical utility in breast cancer screening and diagnosis to support continuing technology development of the investigational technology.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
35 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is female of any race and ethnicity.
  • Subject is at least 35 years old.
  • Subject is indicated for a screening or diagnostic mammogram or breast biopsy.

排除标准

  • Subject is pregnant or thinks she may be pregnant
  • Subject has breast implants, cardiac pacemakers, nipple piercings, or IV ports in the mammography field of view.
  • Subject previously participated in the study.

研究组 & 干预措施

Investigational Mammogram Exam

Experimental

干预措施: Mammography (Device)

结局指标

主要结局

Clinically acceptable image quality of the Investigational Device.

时间窗: 4 years

Questionnaire will be used to measure outcomes

Mammograms can be safety acquired on the Investigational Device.

时间窗: 4 years

Will be determined using the AE assessment.

次要结局

  • The ease of positioning and usability of the Investigational Device.(4 years)
  • Subject assessment of comfort of the Investigational Device.(4 years)

研究者

发起方
Hologic, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (29)

Loading locations...

相似试验